Picture of Neurobiological Technologies logo

NTII Neurobiological Technologies Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual income statement for Neurobiological Technologies, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

R2005
June 30th
2006
June 30th
2007
June 30th
2008
June 30th
2009
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue3.112.317.714.826.4
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses28.340.333.333.223.9
Operating Profit-25.2-27.9-15.6-18.52.48
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-25-27.5-14.1-16.33.12
Provision for Income Taxes
Net Income After Taxes-25-27.8-14.1-16.33.12
Net Income Before Extraordinary Items
Net Income-25-27.8-14.1-16.33.12
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-25-27.8-14.1-16.33.12
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-3.25-4.01-3.26-0.7480.161
Dividends per Share